Original Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jan 21, 2009; 15(3): 310-320
Published online Jan 21, 2009. doi: 10.3748/wjg.15.310
Figure 4
Figure 4 Cell viability measured by hemocytometry. Viability of the troglitazone- or ciglitazone-treated cells was decreased more than that of the control group, with no significant difference between the two cell lines.